The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells

Isocitrate dehydrogenase 2 (IDH2) is located in the mitochondrial matrix. IDH2 acts in the forward Krebs cycle as an NADP+-consuming enzyme, providing NADPH for maintenance of the reduced glutathione and peroxiredoxin systems and for self-maintenance by reactivation of cystine-inactivated IDH2 by gl...

Full description

Saved in:
Bibliographic Details
Main Authors: Katarína Smolková, Petr Ježek
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2012/273947
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548574404018176
author Katarína Smolková
Petr Ježek
author_facet Katarína Smolková
Petr Ježek
author_sort Katarína Smolková
collection DOAJ
description Isocitrate dehydrogenase 2 (IDH2) is located in the mitochondrial matrix. IDH2 acts in the forward Krebs cycle as an NADP+-consuming enzyme, providing NADPH for maintenance of the reduced glutathione and peroxiredoxin systems and for self-maintenance by reactivation of cystine-inactivated IDH2 by glutaredoxin 2. In highly respiring cells, the resulting NAD+ accumulation then induces sirtuin-3-mediated activating IDH2 deacetylation, thus increasing its protective function. Reductive carboxylation of 2-oxoglutarate by IDH2 (in the reverse Krebs cycle direction), which consumes NADPH, may follow glutaminolysis of glutamine to 2-oxoglutarate in cancer cells. When the reverse aconitase reaction and citrate efflux are added, this overall “anoxic” glutaminolysis mode may help highly malignant tumors survive aglycemia during hypoxia. Intermittent glycolysis would hypothetically be required to provide ATP. When oxidative phosphorylation is dormant, this mode causes substantial oxidative stress. Arg172 mutants of human IDH2—frequently found with similar mutants of cytosolic IDH1 in grade 2 and 3 gliomas, secondary glioblastomas, and acute myeloid leukemia—catalyze reductive carboxylation of 2-oxoglutarate and reduction to D-2-hydroxyglutarate, which strengthens the neoplastic phenotype by competitive inhibition of histone demethylation and 5-methylcytosine hydroxylation, leading to genome-wide histone and DNA methylation alternations. D-2-hydroxyglutarate also interferes with proline hydroxylation and thus may stabilize hypoxia-induced factor α.
format Article
id doaj-art-e5765ce857d6438dae282e10ebb3d95a
institution Kabale University
issn 1687-8876
1687-8884
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-e5765ce857d6438dae282e10ebb3d95a2025-02-03T06:13:51ZengWileyInternational Journal of Cell Biology1687-88761687-88842012-01-01201210.1155/2012/273947273947The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer CellsKatarína Smolková0Petr Ježek1Department of Membrane Transport Biophysics (No. 75), Institute of Physiology v.v.i., Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-14220 Prague, Czech RepublicDepartment of Membrane Transport Biophysics (No. 75), Institute of Physiology v.v.i., Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-14220 Prague, Czech RepublicIsocitrate dehydrogenase 2 (IDH2) is located in the mitochondrial matrix. IDH2 acts in the forward Krebs cycle as an NADP+-consuming enzyme, providing NADPH for maintenance of the reduced glutathione and peroxiredoxin systems and for self-maintenance by reactivation of cystine-inactivated IDH2 by glutaredoxin 2. In highly respiring cells, the resulting NAD+ accumulation then induces sirtuin-3-mediated activating IDH2 deacetylation, thus increasing its protective function. Reductive carboxylation of 2-oxoglutarate by IDH2 (in the reverse Krebs cycle direction), which consumes NADPH, may follow glutaminolysis of glutamine to 2-oxoglutarate in cancer cells. When the reverse aconitase reaction and citrate efflux are added, this overall “anoxic” glutaminolysis mode may help highly malignant tumors survive aglycemia during hypoxia. Intermittent glycolysis would hypothetically be required to provide ATP. When oxidative phosphorylation is dormant, this mode causes substantial oxidative stress. Arg172 mutants of human IDH2—frequently found with similar mutants of cytosolic IDH1 in grade 2 and 3 gliomas, secondary glioblastomas, and acute myeloid leukemia—catalyze reductive carboxylation of 2-oxoglutarate and reduction to D-2-hydroxyglutarate, which strengthens the neoplastic phenotype by competitive inhibition of histone demethylation and 5-methylcytosine hydroxylation, leading to genome-wide histone and DNA methylation alternations. D-2-hydroxyglutarate also interferes with proline hydroxylation and thus may stabilize hypoxia-induced factor α.http://dx.doi.org/10.1155/2012/273947
spellingShingle Katarína Smolková
Petr Ježek
The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
International Journal of Cell Biology
title The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
title_full The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
title_fullStr The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
title_full_unstemmed The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
title_short The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
title_sort role of mitochondrial nadph dependent isocitrate dehydrogenase in cancer cells
url http://dx.doi.org/10.1155/2012/273947
work_keys_str_mv AT katarinasmolkova theroleofmitochondrialnadphdependentisocitratedehydrogenaseincancercells
AT petrjezek theroleofmitochondrialnadphdependentisocitratedehydrogenaseincancercells
AT katarinasmolkova roleofmitochondrialnadphdependentisocitratedehydrogenaseincancercells
AT petrjezek roleofmitochondrialnadphdependentisocitratedehydrogenaseincancercells